VEND medicines exceed £2 million in November 2019
Posted in News
VEND achieved an impressive milestone in November 2019 by crossing £2 million of submitted stock which is helping to achieve the Carter target efficiencies, better use of NHS resources and a general feeling of doing something very positive for Trusts.
For those of you not familiar with VEND, it was developed to achieve Value from Expiring NHS Drugs. It is an online virtual marketplace for medicines approaching their expiry date. It allows hospital pharmacies to list expiring drugs with quantity, expiry date, price and contact details. Once listed, these drugs are visible to all trusts in the UK that have access to VEND.
Pharmacies are then able to get in touch with the vendor to carry out pharmacy-to-pharmacy transactions after agreeing a fee and carriage method with the selling Trust. Since 2016 VEND has seen over £2 million worth of unrequired stock listed. This figure is only set to increase with the new links between Exend and VEND.
To learn more about what is available on VEND, subscribe here.
Exend has been developed to allow all UK NHS Hospital Trusts to monitor their own purchasing and stock level data. With increased data on usage and estimated usage, Exend has the function to allow stock to be listed on Vend via a link next to the stock level of the VMP in question.
Please note medicines may not be listed for more than the price originally paid. Rx-info will not negotiate on behalf of a buyer or seller (though we act as the match maker). Rx-info receives no fee or percentage from individual transactions.
For more information on compliance with legislation please take a look at this MHRA guidance.
More than half of all hospital pharmacists now have an account and access to Rx-info products.